XASX
EIQ
Market cap124mUSD
May 15, Last price
0.30AUD
1D
0.00%
1Q
7.14%
Jan 2017
-56.52%
IPO
-87.56%
Name
EchoIQ Ltd
Chart & Performance
Profile
Echo IQ Limited provides cardiac diagnostics support solution in Australia. The company offers artificial intelligence-assisted diagnostics technology that enhance the diagnosis of structural heart disease, as well as Aortic Stenosis. It primarily serves physicians, health systems, and patients. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Sydney, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 44 -58.54% | 107 -57.26% | 251 -43.19% | |||||||
Cost of revenue | 7,165 | 11,598 | 6,782 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (7,120) | (11,491) | (6,531) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | 3 | (499) | ||||||||
Tax Rate | ||||||||||
NOPAT | (7,120) | (11,491) | (6,033) | |||||||
Net income | (5,409) -34.56% | (8,266) 37.95% | (5,992) 100.12% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 2,765 | 5,692 | 1,379 | |||||||
BB yield | -3.09% | -8.47% | -3.05% | |||||||
Debt | ||||||||||
Debt current | 1 | |||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 1 | |||||||||
Net debt | (2,122) | (3,281) | (2,411) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (3,924) | (4,940) | (2,585) | |||||||
CAPEX | (4) | (340) | (367) | |||||||
Cash from investing activities | (60) | (367) | ||||||||
Cash from financing activities | 2,765 | 5,879 | 1,547 | |||||||
FCF | (7,100) | (11,485) | (6,040) | |||||||
Balance | ||||||||||
Cash | 2,117 | 3,276 | 2,407 | |||||||
Long term investments | 5 | 5 | 5 | |||||||
Excess cash | 2,120 | 3,276 | 2,399 | |||||||
Stockholders' equity | 6,768 | 7,383 | 8,020 | |||||||
Invested Capital | 4,648 | 4,097 | 5,621 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 497,592 | 448,036 | 392,826 | |||||||
Price | 0.18 20.00% | 0.15 30.43% | 0.12 9.52% | |||||||
Market cap | 89,567 33.27% | 67,205 48.77% | 45,175 55.39% | |||||||
EV | 87,445 | 63,924 | 42,764 | |||||||
EBITDA | (6,516) | (10,884) | (5,891) | |||||||
EV/EBITDA | ||||||||||
Interest | 2 | |||||||||
Interest/NOPBT |